Skip to content

Evaluation of DNA damage in anesthesiologists

Damage assessment in the genetic material in anesthesiologists

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-4vrz2m
Enrollment
Unknown
Registered
2015-03-25
Start date
2014-05-07
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DNA damage of anesthesiologists.

Interventions

Experimental group: 30 medical occupationally exposed to residues of inhaled anesthetics. Control group: 30 medical nonexposed waste of inhaled anesthetics. Both groups will be submitted to the collec
Other
E01.370.225.998.110
A10.615.550.599

Sponsors

Departamento de Anestesiologia
Lead Sponsor
Faculdade de Medicina de Botucatu
Collaborator

Eligibility

Age
23 Years to 75 Years

Inclusion criteria

Inclusion criteria: Anesthesiologists to compose the exposed group medical and clinical settings to compose the control group; healthy volunteers; both genders; non-smoking; age between 23 to 75 years.

Exclusion criteria

Exclusion criteria: Malignants diseases; infectious diseases; inflammatory diseases; alcohol consumption; use of tobacco; illicit drug use; use of medications; use of vitamin supplementation; radiation exposure.

Design outcomes

Primary

MeasureTime frame
It is expected to find increased DNA damage in the exposed group of participants through the comet assay in lymphocytes analyzed by fluorescence microscopy images with the aid of a software capable of detecting the intensity of the tail, and the higher the tail damage . Increase of cytogenetic damage in the DNA of the exposed participants are also expected by the micronucleus test in the oral mucosa cells, assessed by light microscopy and determined by the presence of micronuclei and nuclear buds by manual counting. The results from both tests are comparative between the exposed and control groups for significant difference check.

Secondary

MeasureTime frame
Are not expected.

Countries

Brazil

Contacts

Public ContactKátina de Souza

Faculdade de Medicina de Botucatu

katinameneghetti@gmail.com5514997933860

Outcome results

None listed

Source: REBEC (via WHO ICTRP)